Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age

Completed · Phase 4

Conditions studied: Influenza, Healthy

In brief

This study is being conducted to compare the immunogenicity, safety, and viral shedding of a new A/H1N1 strain that will be incorporated into the FluMist quadrivalent formulation for the 2017-2018 influenza season with the previous A/H1N1 strain that was included in the vaccine in the 2015-2016 influenza season.

Key facts

Study ID

NCT03143101

Run by

MedImmune LLC

People needed

200

Starts

2017-05-08

Expected to finish

2017-09-29

Last updated by the study team

2018-12-11

Who can join

Age: 2 and older, up to 4. Sex: any. Healthy volunteers: accepted.

Where it is running

• Research Site — Savannah, Georgia, United States
• Research Site — Bardstown, Kentucky, United States
• Research Site — St Louis, Missouri, United States
• Research Site — Norfolk, Nebraska, United States
• Research Site — Omaha, Nebraska, United States
• Research Site — Binghamton, New York, United States
• Research Site — Dakota Dunes, South Dakota, United States
• Research Site — Fort Worth, Texas, United States
• Research Site — San Angelo, Texas, United States
• Research Site — Tomball, Texas, United States
• Research Site — Salt Lake City, Utah, United States
• Research Site — West Jordan, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.